5:57 PM
 | 
Jan 24, 2013
 |  BC Extra  |  Top Story

Ariad raises $300 million in follow-on

Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) raised $300 million through the sale of 15.3 million shares at $19.60 in a follow-on underwritten by JPMorgan; Cowen; Jefferies;...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >